Rankings
▼
Calendar
BEAM Q4 2021 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$51M
+851050.0% YoY
Gross Profit
$109M
213.9% margin
Operating Income
-$63M
-124.3% margin
Net Income
-$65M
-126.7% margin
EPS (Diluted)
$-0.95
QoQ Revenue Growth
+6593.2%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
-$12M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$1.5B
Total Liabilities
$648M
Stockholders' Equity
$827M
Cash & Equivalents
$560M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$51M
$6,000
+851050.0%
Gross Profit
$109M
-$32M
+436.7%
Operating Income
-$63M
-$41M
-55.6%
Net Income
-$65M
-$95M
+32.2%
← FY 2021
All Quarters
Q1 2022 →